Acute Lymphoid Leukemia

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Erwinase Master Treatment Protocol

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Study of the Medullary Microenvironment in Acute Childhood Leukemia

Muscle Dysfunction in Patients With Haematological Diseases

PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

Latin American Real-world Study in Acute Leukemia